Morishita Jintan Co 4524.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4524.T. It has been listed since 2 October 1961. In the fiscal year to 31 March 2026, it reported revenue of ¥12.69bn and net income of ¥628.0m. At that date it held total assets of ¥18.62bn and shareholders' equity of ¥12.98bn.

Morishita Jintan Co., Ltd. engages in the manufacture and sale of pharmaceutical products, quasi-drugs, medical devices, and food products. The company is headquartered in Osaka, Osaka-Fu. The firm operates in two segments. The Healthcare segment provides health-related products through Internet and major domestic companies. The Capsules segment is engaged in the contracting business of capsule bulks to food manufacturers and pharmaceutical manufacturers.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Yuji MorishitaPresident, Chief Executive Officer, Representative Director, since 2012
• Mr. Hidetsugu IshidaManaging Executive Officer, Chief Director of Healthcare Business, Chief Director of Capsule Business
• Mr. Hideaki YoshidaExecutive Officer, Chief Director of Administration
• Mr. Noriyuki JinushiExecutive Officer, Manager of Business Planning
• Mr. Kenji MitsunagaDirector
• Mr. Satoshi IshiguroIndependent Director
• Ms. Mayumi IshiharaIndependent Director
• Ms. Yoshie OkochiIndependent Director
• Mr. Hisayuki SuekawaIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.